Has Sandeep Kour, MD received payments from drug or device companies?

Yes. Drug and device makers reported $34,266 in general payments to Sandeep Kour, MD across 342 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sandeep Kour, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sandeep Kour, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sandeep Kour, MD

Endocrinology, Diabetes & Metabolism · Emerson, NJNPI 1083037915

Payments from drug & device makers

$34,266in general payments, 2019–2025

Across 342 payments — averaging $100.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corcept Therapeutics$19K
Ascendis Pharma Endocrinology Inc$9K
Amgen$1K
Novo Nordisk$1K
Lilly USA, LLC$784
AstraZeneca$455
plus $3K from 35 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corcept Therapeutics	69	$18,821
Ascendis Pharma Endocrinology Inc	14	$8,583
Amgen(2 entities)	27	$1,174
Novo Nordisk	45	$1,047
Lilly USA, LLC	35	$784
AstraZeneca(2 entities)	16	$455
Medtronic	8	$389
Boehringer Ingelheim	12	$381
Xeris Pharmaceuticals, Inc.	15	$340
Astellas Pharma US Inc	5	$262
Takeda Pharmaceuticals U.S.A., Inc.	15	$243
QOL Medical, LLC	8	$195
IBSA Pharma Inc.	4	$172
Asensus Surgical, Inc.	3	$165
Insulet Corporation	7	$162
Johnson & Johnson(2 entities)	7	$120
Mannkind Corporation	2	$119
AbbVie	8	$115
Radius Health, Inc.	5	$89
Ardelyx, Inc.	4	$73
Regeneron Healthcare Solutions, Inc.	4	$66
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$60
Merck	3	$48
Kyowa Kirin, Inc.	2	$38
Abbott	2	$37
Braintree Laboratories, Inc.	2	$35
Tandem Diabetes Care, Inc.	1	$32
Exact Sciences	1	$29
Amarin Pharma, Inc.	2	$27
Dexcom, Inc.	1	$21
Amryt Pharma Holdings Ltd	1	$20
Blueprint Medicines Corporation	1	$20
Phathom Pharmaceuticals, Inc.	1	$19
Biocon Biologics Inc	1	$18
Biohaven Pharmaceutical Holding Company Ltd.	1	$18
Azurity Pharmaceuticals, Inc.	1	$17
Cequr Corporation	1	$16
UCB, Inc.	1	$15
Intercept Pharmaceuticals, Inc.	1	$14
Sanofi-aventis U.S. LLC	1	$13
Arbor Pharmaceuticals, Inc.	1	$13

How this compares

$34,266 in reported general payments places this provider in the 90th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey →

Medicare billing

Part B allowed, 2024

$322,184

Medicare patients

447

Services billed

14,103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Emerson

Barry GertzRahway$903K
Nawras MakhsidaRandolph$882K
Marc SandbergFlemington$567K
Joanne WaldstreicherNew Brunswick$441K
Gregory BaroneCherry Hill$433K
Taher ModarressiPennington$414K
Navtika DesaiHillsborough$408K
Atara SchultzTeaneck$357K
Anthony CannonTurnersville$296K
Sunil AsnaniBrick$295K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →